Marc Chimowitz

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. pmc Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial
    Marc I Chimowitz
    Department of Neurosciences, Stroke Center, Medical University of South Carolina, Charleston, USA
    J Stroke Cerebrovasc Dis 20:357-68. 2011
  2. pmc Stenting versus aggressive medical therapy for intracranial arterial stenosis
    Marc I Chimowitz
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
    N Engl J Med 365:993-1003. 2011
  3. ncbi request reprint Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
    Bruce Ovbiagele
    Stroke Center, Department of Neurology, UCLA Medical Center, Los Angeles, CA, USA
    Neurology 66:1344-9. 2006

Research Grants

Detail Information

Publications3

  1. pmc Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial
    Marc I Chimowitz
    Department of Neurosciences, Stroke Center, Medical University of South Carolina, Charleston, USA
    J Stroke Cerebrovasc Dis 20:357-68. 2011
    ....
  2. pmc Stenting versus aggressive medical therapy for intracranial arterial stenosis
    Marc I Chimowitz
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
    N Engl J Med 365:993-1003. 2011
    ..However, PTAS has not been compared with medical management in a randomized trial...
  3. ncbi request reprint Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
    Bruce Ovbiagele
    Stroke Center, Department of Neurology, UCLA Medical Center, Los Angeles, CA, USA
    Neurology 66:1344-9. 2006
    ..The authors evaluated the prevalence and prognosis of the MetS among individuals with symptomatic intracranial arterial stenosis...

Research Grants10

  1. WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSIS
    Marc Chimowitz; Fiscal Year: 2002
    ..e., greater than or equal to 6 percent per year) to justify a subsequent trial comparing intracranial angioplasty with best medical therapy in these patients. ..